Nordson(US:NDSN) ZACKSยท2024-12-12 00:01Core Insights - Nordson reported revenue of $744.48 million for the quarter ended October 2024, marking a year-over-year increase of 3.5% and exceeding the Zacks Consensus Estimate by 1.52% [1] - The company's EPS for the same period was $2.78, up from $2.46 a year ago, representing a surprise of 7.34% over the consensus estimate of $2.59 [1] Revenue Performance - Net Sales in Industrial Precision Solutions were $392.15 million, which is a decrease of 3.3% compared to the year-ago quarter and below the average estimate of $407.64 million [3] - Net Sales in Advanced Technology Solutions reached $152.11 million, reflecting a year-over-year increase of 4.7% and surpassing the average estimate of $135.17 million [3] - Net Sales in Medical and Fluid Solutions amounted to $200.22 million, an 18.7% increase year-over-year, exceeding the average estimate of $197.55 million [3] Operating Profit Analysis - Operating profit in Advanced Technology Solutions was $33.46 million, exceeding the average estimate of $25.76 million [3] - Operating profit in Medical and Fluid Solutions was $44.26 million, which fell short of the average estimate of $50.14 million [3] - Operating profit in Industrial Precision Solutions was $126.25 million, below the average estimate of $136.06 million [3] - Corporate operating loss was reported at -$25.09 million, worse than the average estimate of -$18.62 million [3] Stock Performance - Over the past month, Nordson's shares have returned -1.8%, contrasting with the Zacks S&P 500 composite's increase of 0.8% [4] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [4]